By Adam Fleischer and Kevin Harris (December 1, 2017, 11:58 AM EST) -- On Nov. 30, 2017, the U.S. Judicial Panel on Multidistrict Litigation, through the U.S. District Court for the Eastern District of Missouri, heard argument from the parties in over 100 lawsuits filed by county and local governments seeking damages from pharmaceutical companies for the opioid epidemic. The plaintiffs who favor consolidation argued that the cases belong in Ohio, whereas the manufacturers argued for consolidation in Chicago or New York, and various distributors supported consolidation in West Virginia. Whether these cases get consolidated and, if so, in which court, may have far reaching implications toward the management and ultimate resolution of the onslaught of opioid claims....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
